Haematopoietic stem cell transplantation (HSCT), using a volunteer unrelated donor, is a well-established treatment for a number of haematologic disorders. In this setting, a HLA match (to allele ...
This study was designed to assess the role of patient–donor HLA matching on the outcomes of unrelated HSCTs performed for haematological malignancies in 805 adult patients in Italy. All Mms were ...
This study did not confirm that UHR 12 out of 12 HLA matching increases the probability of overall survival but does demonstrate that aGVHD risk, and in certain settings TRM, is lowest in UHR ...
Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving therapy for several blood cancers and other diseases. For patients without a suitable related HLA-matched donor, ...
HLA testing has been a staple in transplantation since the recognition that antibodies, directed against lymphocytes, were associated with allograft failure. This seminal finding led to the discovery ...
Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells. Rates of graft-versus-host disease (GVHD), graft failure, relapse, and non ...
Please provide your email address to receive an email when new articles are posted on . For years, hematopoietic stem cell transplantation physicians have viewed a matched unrelated donor as the gold ...
To the Editor: Petersdorf et al. (Dec. 20 issue) 1 suggest that for patients with chronic myelogenous leukemia for whom a donor with an HLA class I mismatch cannot be avoided, “the preferred . . .
Jayme Locke, MD MARCO ISLAND, Fla.—The transplant community may want to rethink the importance of HLA mismatches when considering live donor kidney transplants, according to new data presented here at ...
Dr Vinky Rughwani Thalassemia and Sickle Cell Centre, in collaboration with Sankalp India Foundation (Bengaluru), held the camp In this camp this test was done free of cost. The patients from ...
On Monday, Citi reiterated its Buy rating on Caribou Biosciences Inc. (NASDAQ:CRBU) stock with a steady price target of $30.00. The firm's analysis suggests that Caribou Biosciences' strategy of ...
Nagpur: Six-year-old Shahbaz along with his parents and elder sister reached Nagpur after 10-hour train journey from Nanded. The only hope that made this poor family to take this hectic journey in ...